Literature DB >> 23069895

[Depression and diabetes mellitus type 2].

M Deuschle1, U Schweiger.   

Abstract

Depression and diabetes mellitus type 2 are frequently comorbid conditions. Both disorders may increase the incidence of the other disorder and impair the prognosis. Thus, it is important for psychiatrists to consider depressed patients as high-risk diabetes subjects to screen for metabolic risks and to consider metabolic risks of antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23069895     DOI: 10.1007/s00115-012-3656-9

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  130 in total

1.  Association of insulin resistance with depression: cross sectional findings from the British Women's Heart and Health Study.

Authors:  Debbie A Lawlor; George Davey Smith; Shah Ebrahim
Journal:  BMJ       Date:  2003-12-13

2.  Genetic predictors of depressive symptoms in cardiac patients.

Authors:  Jeanne M McCaffery; Qing Ling Duan; Nancy Frasure-Smith; Amina Barhdadi; Francois Lespérance; Pierre Théroux; Guy A Rouleau; Marie-Pierre Dubé
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-04-05       Impact factor: 3.568

3.  Metabolic changes in elderly patients with major depression: evidence for increased accumulation of visceral fat at follow-up.

Authors:  Bettina Weber-Hamann; Marc Werner; Frank Hentschel; Nils Bindeballe; Florian Lederbogen; Michael Deuschle; Isabella Heuser
Journal:  Psychoneuroendocrinology       Date:  2005-10-06       Impact factor: 4.905

4.  Quality of early mother-child interaction associated with depressive psychopathology in the offspring: a prospective study from infancy to adulthood.

Authors:  Brigitte Schmid; Dorothea Blomeyer; Arlette F Buchmann; Patricia Trautmann-Villalba; Ulrich S Zimmermann; Martin H Schmidt; Günter Esser; Tobias Banaschewski; Manfred Laucht
Journal:  J Psychiatr Res       Date:  2011-06-16       Impact factor: 4.791

5.  Association of depression and diabetes complications: a meta-analysis.

Authors:  M de Groot; R Anderson; K E Freedland; R E Clouse; P J Lustman
Journal:  Psychosom Med       Date:  2001 Jul-Aug       Impact factor: 4.312

6.  Treatment adjustment and medication adherence for complex patients with diabetes, heart disease, and depression: a randomized controlled trial.

Authors:  Elizabeth H B Lin; Michael Von Korff; Paul Ciechanowski; Do Peterson; Evette J Ludman; Carolyn M Rutter; Malia Oliver; Bessie A Young; Jochen Gensichen; Mary McGregor; David K McCulloch; Edward H Wagner; Wayne J Katon
Journal:  Ann Fam Med       Date:  2012 Jan-Feb       Impact factor: 5.166

7.  Depression and diabetes symptom burden.

Authors:  Evette J Ludman; Wayne Katon; Joan Russo; Michael Von Korff; Gregory Simon; Paul Ciechanowski; Elizabeth Lin; Terry Bush; Edward Walker; Bessie Young
Journal:  Gen Hosp Psychiatry       Date:  2004 Nov-Dec       Impact factor: 3.238

Review 8.  Human fat cell lipolysis: biochemistry, regulation and clinical role.

Authors:  Peter Arner
Journal:  Best Pract Res Clin Endocrinol Metab       Date:  2005-12       Impact factor: 4.690

9.  An assessment of attitudes, behaviors, and outcomes of patients with type 2 diabetes.

Authors:  Jeanette M Daly; Arthur J Hartz; Yinghui Xu; Barcey T Levy; Paul A James; Mary L Merchant; Robert E Garrett
Journal:  J Am Board Fam Med       Date:  2009 May-Jun       Impact factor: 2.657

10.  Prospective study of social and other risk factors for incidence of type 2 diabetes in the Whitehall II study.

Authors:  Meena Kumari; Jenny Head; Michael Marmot
Journal:  Arch Intern Med       Date:  2004-09-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.